New eczema cream shows promise in early trial
NCT ID NCT07071610
First seen Jan 15, 2026 · Last updated May 15, 2026 · Updated 22 times
Summary
This study tested whether a new ointment called LNK01004 can safely improve symptoms of atopic dermatitis (eczema) in adults. 75 people with moderate-to-severe eczema applied either a low dose, high dose, or a placebo cream twice daily for 8 weeks. The main goal was to see how much their eczema severity score changed from the start to the end of treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Peking University People's Hospital
Beijing, China
Conditions
Explore the condition pages connected to this study.